Pune, Oct. 12, 2022 (GLOBE NEWSWIRE) — According to a new market research report titled, “Animal Health Market by Product (Mobile Computing, Medication Carts, Wall-Mounted Workstations), by Type (Emergency Cart, Anesthesia Cart, Procedure Cart), and End-User (Hospitals, Ambulatory Surgical Centers, Home Care Centers, Diagnostic Centers) – Global Outlook & Forecast 2022-2030″ published by Growth Plus Reports, the Animal Health Market is expected to grow at a CAGR of 9.8% from 2021 to reach US$ 90.33 billion by 2030.
Download PDF Brochure on Animal Health Market Size – COVID-19 Impact and Global Analysis with Strategic Developments at: https://growthplusreports.com/inquiry/request-sample/animal-health-market/7874
Animal health refers to the appropriate care of the animals’ health via medications, animal feeds, diagnostics, and immunizations. Like people, animals have a variety of illnesses, necessitating veterinary care. The animal health market’s major goal is to improve the health and welfare of animals. This market offers a variety of goods and services that improve livestock production and animal health. These goods and services are prescription medications, immunizations, food, dietary supplements, and many others.
The market for animal health is expanding at a significant rate. The rise in animal and foodborne illnesses is to blame for this expansion. Animal-borne diseases are spreading worldwide due to increased pet adoption for companionship, raising demands for animal health products and services. Additionally, variables such as an increase in the number of companion animals, a growth in the need for pet insurance, and rising income levels in industrialized countries all play a role. Additionally, increasing technical development for zoonotic disease diagnostics, increased approvals for innovative goods and medications, and improvements in vaccinations help expand the market. Moreover, rising government efforts, rising corporate mergers, and acquisitions, and rising spending on animal health all contribute to market development.
The animal health market has been analyzed from four perspectives: product, animal type, end-users, and region.
Excerpts from ‘By Product Segmentation’
The product in the animal health market has been segmented into:
The market’s highest revenue share belongs to the pharmaceutical sector. The rise in the incidence of animal illnesses, the expanding use of medicines for therapeutic purposes, and the increase in the ownership of companion animals are all factors contributing to the expansion of this market. Rising acquisition and cooperation rates can also be seen as a significant influence on this segment’s overall growth.
However, the diagnostics market is anticipated to expand significantly due to the increased incidence of animal illnesses and rising costs for animal health. The continued acceptance of innovative products, technological improvements, and growing demand for point-of-care diagnostics (such as pregnancy tests, blood glucose monitors, etc.) enhance segment development.
Inquiry Before Buying: https://growthplusreports.com/inquiry/before-buying/animal-health-market/7874
Excerpts from ‘By Region Segmentation’
The global animal health market has been segmented into:
- North America
- Asia Pacific
- Rest of the World
North America holds the largest revenue share in the market. Technology developments, an increase in zoonotic illnesses, and an increase in the number of pet owners in the country are just a few of the reasons why the animal health industry in this region is expanding. These elements have also enabled government animal welfare groups to employ various successful strategies. The Europe region is likely to maintain the second position in this market, with consistent growth forecast over the long term. The market is growing due to increased consumption of animal-based foods and strict animal health regulations.
Excerpts from ‘Competitive Landscape’
Some prominent players operating in the animal health market are:
- Novartis AG
- Bayer AG
- Intervet International B.V
- Boehringer Ingelheim International GmbH
- Emergent BioSolutions Inc
- Elanco Animal Health Incorporated
- Emergent BioSolutions Inc
- Merck & Co. Inc
- IDEXX Laboratories Inc
- Zoetis Inc
- Vetoquinol S.A
- Ceva Santé Animale
Table of Content
- Market Ecosystem
- Timeline Under Consideration
- Historical Years – 2020
- Base Year – 2021
- Forecasted Years – 2022 to 2030
- Currency Used in the Report
- RESEARCH METHODOLOGY
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
- Current Market Trends (COVID-19 Perspective)
- Key Players & Competitive Positioning (2021)
- MARKET DYNAMICS
- GLOBAL ANIMAL HEALTH MARKET- ANALYSIS & FORECAST, BY PRODUCT
- GLOBAL ANIMAL HEALTH MARKET- ANALYSIS & FORECAST, BY ANIMAL TYPE
- Companion Animals
- Farm Animals
- GLOBAL ANIMAL HEALTH MARKET- ANALYSIS & FORECAST, BY END-USER
- Animal Care and Rehabilitation Centers
- Diagnostic Centers
- Veterinary Hospitals and Clinics
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- ‘Business Profile’ of Key Players
Directly Purchase Premium Copy of Animal Health Market Growth Report (2022-2030) at: https://growthplusreports.com/checkout?_token=4xCWqOVomdTRGQTHHJ6OgDdgQFD5fwKyJWTmN65E&report_id=7874&license=Single
Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.